|
Q
|
GWAS1248821_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248821 (human)
|
|
IAGP
|
rs10137103
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr14:106,703,184...106,703,185
|
|
Q
|
GWAS1248926_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248926 (human)
|
|
IAGP
|
rs78722160
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr16:5,629,108...5,629,109
|
|
Q
|
GWAS1248927_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248927 (human)
|
|
IAGP
|
rs1131543
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr16:28,986,676...28,986,677
|
|
Q
|
GWAS1248928_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248928 (human)
|
|
IAGP
|
rs10947290
| 5.0E-16 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,478,492...32,478,493
|
|
Q
|
GWAS1248929_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1248929 (human)
|
|
IAGP
|
rs3094106
| 7.0E-11 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:30,631,399...30,631,400
|
|
Q
|
GWAS1274944_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1274944 (human)
|
|
IAGP
|
rs2793484
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr13:24,185,159...24,185,160
|
|
Q
|
GWAS1274945_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1274945 (human)
|
|
IAGP
|
rs4493049
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr16:80,012,872...80,012,873
|
|
Q
|
GWAS1274947_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1274947 (human)
|
|
IAGP
|
rs10140983
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr14:93,891,857...93,891,858
|
|
Q
|
GWAS1275399_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275399 (human)
|
|
IAGP
|
rs13434443
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 4:64,448,035...64,448,036
|
|
Q
|
GWAS1275400_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275400 (human)
|
|
IAGP
|
rs12085736
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:85,499,025...85,499,026
|
|
Q
|
GWAS1275401_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275401 (human)
|
|
IAGP
|
rs12632157
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 3:87,616,630...87,616,631
|
|
Q
|
GWAS1275618_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275618 (human)
|
|
IAGP
|
rs12942506
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr17:33,499,023...33,499,024
|
|
Q
|
GWAS1275619_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275619 (human)
|
|
IAGP
|
rs4481876
| 1.0E-5 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:7,274,680...7,274,681
|
|
Q
|
GWAS1275620_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275620 (human)
|
|
IAGP
|
rs2376034
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:102,433,268...102,433,269
|
|
Q
|
GWAS1275621_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275621 (human)
|
|
IAGP
|
rs9975383
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr21:40,495,416...40,495,417
|
|
Q
|
GWAS1275622_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275622 (human)
|
|
IAGP
|
rs13433685
| 1.0E-5 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 3:177,037,120...177,037,121
|
|
Q
|
GWAS1275623_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275623 (human)
|
|
IAGP
|
rs13434443
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 4:64,448,035...64,448,036
|
|
Q
|
GWAS1275624_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275624 (human)
|
|
IAGP
|
rs17396376
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr16:64,066,290...64,066,291
|
|
Q
|
GWAS1275625_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1275625 (human)
|
|
IAGP
|
rs638335
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:78,062,192...78,062,193
|
|
Q
|
GWAS1391871_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391871 (human)
|
|
IAGP
|
rs9275109
| 1.0E-26 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 6:32,681,899...32,681,900
|
|
Q
|
GWAS1391872_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391872 (human)
|
|
IAGP
|
rs79510369
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 2:160,001,537...160,001,538
|
|
Q
|
GWAS1391873_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391873 (human)
|
|
IAGP
|
rs68033958
| 1.0E-21 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 6:32,666,449...32,666,450
|
|
Q
|
GWAS1391874_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1391874 (human)
|
|
IAGP
|
rs3094055
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:39384777 |
|
NCBI chr 6:30,364,369...30,364,370
|
|
Q
|
GWAS1416854_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416854 (human)
|
|
IAGP
|
rs12489684
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:67,503,800...67,503,801
|
|
Q
|
GWAS1416855_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416855 (human)
|
|
IAGP
|
rs4799419
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr18:36,510,951...36,510,952
|
|
Q
|
GWAS1416856_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416856 (human)
|
|
IAGP
|
rs5994195
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr22:17,197,777...17,197,778
|
|
Q
|
GWAS1416857_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416857 (human)
|
|
IAGP
|
rs10906319
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr10:13,178,143...13,178,144
|
|
Q
|
GWAS1416858_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1416858 (human)
|
|
IAGP
|
rs17072962
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 6:143,713,654...143,713,655
|
|
Q
|
GWAS1416859_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416859 (human)
|
|
IAGP
|
rs72737661
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:84,688,251...84,688,252
|
|
Q
|
GWAS1416860_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416860 (human)
|
|
IAGP
|
rs149813122
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:17,557,558...17,557,559
|
|
Q
|
GWAS1416861_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416861 (human)
|
|
IAGP
|
rs180977908
| 9.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr12:116,414,208...116,414,209
|
|
Q
|
GWAS1416862_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416862 (human)
|
|
IAGP
|
rs12492145
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:191,266,812...191,266,813
|
|
Q
|
GWAS1416863_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416863 (human)
|
|
IAGP
|
rs72715264
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:28,773,701...28,773,702
|
|
Q
|
GWAS1416864_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1416864 (human)
|
|
IAGP
|
rs200076663
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr13:60,294,764...60,294,765
|
|
Q
|
GWAS1417086_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1417086 (human)
|
|
IAGP
|
rs4543780
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 1:231,038,685...231,038,686
|
|
Q
|
GWAS1417087_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1417087 (human)
|
|
IAGP
|
rs10798156
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 1:188,009,513...188,009,514
|
|
Q
|
GWAS1417088_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1417088 (human)
|
|
IAGP
|
rs117744190
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:34,517,105...34,517,106
|
|
Q
|
GWAS1417780_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417780 (human)
|
|
IAGP
|
rs13094466
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:59,957,291...59,957,292
|
|
Q
|
GWAS1417781_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417781 (human)
|
|
IAGP
|
rs1921111
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:30,870,751...30,870,752
|
|
Q
|
GWAS1417782_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417782 (human)
|
|
IAGP
|
rs755295
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:27,794,997...27,794,998
|
|
Q
|
GWAS1417783_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417783 (human)
|
|
IAGP
|
rs12548840
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 8:99,885,580...99,885,581
|
|
Q
|
GWAS1417784_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417784 (human)
|
|
IAGP
|
rs115391410
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:55,046,103...55,046,104
|
|
Q
|
GWAS1417786_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417786 (human)
|
|
IAGP
|
rs4630823
| 9.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:56,534,912...56,534,913
|
|
Q
|
GWAS1417787_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417787 (human)
|
|
IAGP
|
rs117761967
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:27,576,974...27,576,975
|
|
Q
|
GWAS1417788_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417788 (human)
|
|
IAGP
|
rs7146742
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr14:65,566,216...65,566,217
|
|
Q
|
GWAS1417789_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417789 (human)
|
|
IAGP
|
rs3779197
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:98,341,212...98,341,213
|
|
Q
|
GWAS1417790_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417790 (human)
|
|
IAGP
|
rs76017198
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:84,708,147...84,708,148
|
|
Q
|
GWAS1417791_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417791 (human)
|
|
IAGP
|
rs4457720
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:106,621,114...106,621,115
|
|
Q
|
GWAS1417792_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417792 (human)
|
|
IAGP
|
rs75953002
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr17:33,615,673...33,615,674
|
|
Q
|
GWAS1417793_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417793 (human)
|
|
IAGP
|
rs74609604
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 7:98,178,332...98,178,333
|
|
Q
|
GWAS1417795_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1417795 (human)
|
|
IAGP
|
rs10977830
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 9:9,515,044...9,515,045
|
|
Q
|
GWAS1539464_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539464 (human)
|
|
IAGP
|
rs2523409
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:29,807,885...29,807,886
|
|
Q
|
GWAS1539466_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539466 (human)
|
|
IAGP
|
rs149566899
| 8.0E-9 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS1539467_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539467 (human)
|
|
IAGP
|
rs3132972
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,262,577...32,262,578
|
|
Q
|
GWAS1539468_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539468 (human)
|
|
IAGP
|
rs2858331
| 8.0E-26 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,713,500...32,713,501
|
|
Q
|
GWAS1539469_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539469 (human)
|
|
IAGP
|
rs751350030
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr13:44,367,675...44,367,676
|
|
Q
|
GWAS1539470_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539470 (human)
|
|
IAGP
|
rs35986240
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,663,214...32,663,215
|
|
Q
|
GWAS1539471_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539471 (human)
|
|
IAGP
|
rs66656759
| 7.0E-14 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:32,663,679...32,663,680
|
|
Q
|
GWAS1539788_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1539788 (human)
|
|
IAGP
|
rs3128911
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:38181733 |
|
NCBI chr 6:29,850,253...29,850,254
|
|
Q
|
GWAS1587497_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1587497 (human)
|
|
IAGP
|
rs671398
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 2:219,706,616...219,706,617
|
|
Q
|
GWAS1587498_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1587498 (human)
|
|
IAGP
|
rs77592003
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:121,406,910...121,406,911
|
|
Q
|
GWAS1587499_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1587499 (human)
|
|
IAGP
|
rs80147812
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr11:58,956,910...58,956,911
|
|
Q
|
GWAS1587500_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587500 (human)
|
|
IAGP
|
rs117838393
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:82,339,985...82,339,986
|
|
Q
|
GWAS1587501_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587501 (human)
|
|
IAGP
|
rs146253416
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:1,449,555...1,449,556
|
|
Q
|
GWAS1587502_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587502 (human)
|
|
IAGP
|
rs117838393
| 9.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr16:82,339,985...82,339,986
|
|
Q
|
GWAS1587503_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587503 (human)
|
|
IAGP
|
rs117118809
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 3:99,677,789...99,677,790
|
|
Q
|
GWAS1587504_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587504 (human)
|
|
IAGP
|
rs718784
| 8.0E-8 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr19:18,047,613...18,047,614
|
|
Q
|
GWAS1587505_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587505 (human)
|
|
IAGP
|
rs35463043
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 2:217,021,378...217,021,379
|
|
Q
|
GWAS1587506_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1587506 (human)
|
|
IAGP
|
rs7269650
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr20:63,071,766...63,071,767
|
|
Q
|
GWAS1587507_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1587507 (human)
|
|
IAGP
|
rs80339225
| 7.0E-10 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr18:59,276,950...59,276,951
|
|
Q
|
GWAS1587508_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1587508 (human)
|
|
IAGP
|
rs2178487
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 5:30,843,681...30,843,682
|
|
Q
|
GWAS1587509_H
|
response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement QTL GWAS1587509 (human)
|
|
IAGP
|
rs13104003
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:36451823 |
|
NCBI chr 4:32,053,616...32,053,617
|
|
Q
|
GWAS1611575_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611575 (human)
|
|
IAGP
|
rs1737060
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:29,765,192...29,765,193
|
|
Q
|
GWAS1611576_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611576 (human)
|
|
IAGP
|
rs12676623
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 8:58,320,850...58,320,851
|
|
Q
|
GWAS1611577_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611577 (human)
|
|
IAGP
|
rs12234024
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:92,577,246...92,577,247
|
|
Q
|
GWAS1611578_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611578 (human)
|
|
IAGP
|
rs844065
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr12:101,572,474...101,572,475
|
|
Q
|
GWAS1611579_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611579 (human)
|
|
IAGP
|
rs327301
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:38,616,010...38,616,011
|
|
Q
|
GWAS1611580_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611580 (human)
|
|
IAGP
|
rs2743941
| 9.0E-8 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:29,787,674...29,787,675
|
|
Q
|
GWAS1611581_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611581 (human)
|
|
IAGP
|
rs61976177
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr14:27,094,703...27,094,704
|
|
Q
|
GWAS1611854_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611854 (human)
|
|
IAGP
|
rs1393221
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:92,602,998...92,602,999
|
|
Q
|
GWAS1611855_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611855 (human)
|
|
IAGP
|
rs1332824
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 1:79,038,687...79,038,688
|
|
Q
|
GWAS1611856_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611856 (human)
|
|
IAGP
|
rs111474511
| 6.0E-7 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr12:120,975,368...120,975,369
|
|
Q
|
GWAS1611857_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611857 (human)
|
|
IAGP
|
rs4716124
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:9,943,012...9,943,013
|
|
Q
|
GWAS1611858_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611858 (human)
|
|
IAGP
|
rs10509790
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr10:105,346,612...105,346,613
|
|
Q
|
GWAS1611859_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611859 (human)
|
|
IAGP
|
rs3118559
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 9:134,468,823...134,468,824
|
|
Q
|
GWAS1611860_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611860 (human)
|
|
IAGP
|
rs72804109
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 5:135,299,948...135,299,949
|
|
Q
|
GWAS1611861_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611861 (human)
|
|
IAGP
|
rs62428487
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:37469131 |
|
NCBI chr 6:149,299,495...149,299,496
|
|
Q
|
GWAS1617366_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1617366 (human)
|
|
IAGP
|
rs28366135
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:38575714 |
|
NCBI chr 6:31,396,328...31,396,329
|
|
Q
|
GWAS1824490_H
|
anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine QTL GWAS1824490 (human)
|
|
IAGP
|
rs9260144
| 1.0E-9 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38181733 |
|
|
|
Q
|
GWAS1832476_H
|
SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1832476 (human)
|
|
IAGP
|
rs1632893
| 2.0E-10 |
|
Based on the EFO term ID
|
GWAS_CATALOG |
PMID:38575714 |
|
|
|
|
Q
|
GWAS1278340_H
|
Epstein-Barr virus seropositivity QTL GWAS1278340 (human)
|
|
IAGP
|
rs1210063
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:36737699 |
|
NCBI chr 6:105,322,133...105,322,134
|
|
Q
|
GWAS1278341_H
|
Epstein-Barr virus seropositivity QTL GWAS1278341 (human)
|
|
IAGP
|
rs71449058
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:36737699 |
|
NCBI chr13:114,072,886...114,072,887
|
|
Q
|
GWAS1345938_H
|
Epstein-Barr virus seropositivity QTL GWAS1345938 (human)
|
|
IAGP
|
rs3135359
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,422,801...32,422,802
|
|
Q
|
GWAS1345939_H
|
Epstein-Barr virus seropositivity QTL GWAS1345939 (human)
|
|
IAGP
|
rs3131283
| 5.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,152,121...32,152,122
|
|
Q
|
GWAS1345940_H
|
Epstein-Barr virus seropositivity QTL GWAS1345940 (human)
|
|
IAGP
|
rs1770449
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 1:236,874,861...236,874,862
|
|
Q
|
GWAS1345941_H
|
Epstein-Barr virus seropositivity QTL GWAS1345941 (human)
|
|
IAGP
|
rs12527758
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,652,509...32,652,510
|
|
Q
|
GWAS1345942_H
|
Epstein-Barr virus seropositivity QTL GWAS1345942 (human)
|
|
IAGP
|
rs17615220
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,709,636...32,709,637
|
|
Q
|
GWAS1345943_H
|
Epstein-Barr virus seropositivity QTL GWAS1345943 (human)
|
|
IAGP
|
rs377743
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,243,288...32,243,289
|
|
Q
|
GWAS1345944_H
|
Epstein-Barr virus seropositivity QTL GWAS1345944 (human)
|
|
IAGP
|
rs75232927
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr10:83,404,030...83,404,031
|
|
Q
|
GWAS1345946_H
|
Epstein-Barr virus seropositivity QTL GWAS1345946 (human)
|
|
IAGP
|
rs4286817
| 3.0E-14 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,641,044...32,641,045
|
|
Q
|
GWAS1346063_H
|
klebsiella phage virus seropositivity QTL GWAS1346063 (human)
|
|
IAGP
|
rs6916742
| 8.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q
|
GWAS1346068_H
|
Epstein-Barr virus seropositivity QTL GWAS1346068 (human)
|
|
IAGP
|
rs2294878
| 4.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,400,018...32,400,019
|
|
Q
|
GWAS1346069_H
|
Epstein-Barr virus seropositivity QTL GWAS1346069 (human)
|
|
IAGP
|
rs9271406
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,619,811...32,619,812
|
|
Q
|
GWAS1346070_H
|
Epstein-Barr virus seropositivity QTL GWAS1346070 (human)
|
|
IAGP
|
rs685810
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,617,175...32,617,176
|
|
Q
|
GWAS1346071_H
|
Epstein-Barr virus seropositivity QTL GWAS1346071 (human)
|
|
IAGP
|
rs6916742
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q
|
GWAS1346072_H
|
Epstein-Barr virus seropositivity QTL GWAS1346072 (human)
|
|
IAGP
|
rs9271406
| 9.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,619,811...32,619,812
|
|
Q
|
GWAS1346073_H
|
Epstein-Barr virus seropositivity QTL GWAS1346073 (human)
|
|
IAGP
|
rs9271857
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,627,370...32,627,371
|
|
Q
|
GWAS1346113_H
|
Epstein-Barr virus seropositivity QTL GWAS1346113 (human)
|
|
IAGP
|
rs9269915
| 6.0E-15 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,583,676...32,583,677
|
|
Q
|
GWAS1346242_H
|
Epstein-Barr virus seropositivity QTL GWAS1346242 (human)
|
|
IAGP
|
rs1980493
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,395,438...32,395,439
|
|
Q
|
GWAS1346243_H
|
Epstein-Barr virus seropositivity QTL GWAS1346243 (human)
|
|
IAGP
|
rs2736157
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,633,043...31,633,044
|
|
Q
|
GWAS1346244_H
|
Epstein-Barr virus seropositivity QTL GWAS1346244 (human)
|
|
IAGP
|
rs9275563
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,135...32,710,136
|
|
Q
|
GWAS1346262_H
|
Epstein-Barr virus seropositivity QTL GWAS1346262 (human)
|
|
IAGP
|
rs3134953
| 1.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,141,388...32,141,389
|
|
Q
|
GWAS1346263_H
|
Epstein-Barr virus seropositivity QTL GWAS1346263 (human)
|
|
IAGP
|
rs3130681
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,912,834...31,912,835
|
|
Q
|
GWAS1346264_H
|
Epstein-Barr virus seropositivity QTL GWAS1346264 (human)
|
|
IAGP
|
rs3130487
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,755,612...31,755,613
|
|
Q
|
GWAS1346265_H
|
Epstein-Barr virus seropositivity QTL GWAS1346265 (human)
|
|
IAGP
|
rs3763354
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,819,140...32,819,141
|
|
Q
|
GWAS1346266_H
|
Epstein-Barr virus seropositivity QTL GWAS1346266 (human)
|
|
IAGP
|
rs9268199
| 5.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,310,858...32,310,859
|
|
Q
|
GWAS1346267_H
|
Epstein-Barr virus seropositivity QTL GWAS1346267 (human)
|
|
IAGP
|
rs1140546
| 3.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,355,111...31,355,112
|
|
Q
|
GWAS1346268_H
|
Epstein-Barr virus seropositivity QTL GWAS1346268 (human)
|
|
IAGP
|
rs1049225
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,659,970...32,659,971
|
|
Q
|
GWAS1346269_H
|
Epstein-Barr virus seropositivity QTL GWAS1346269 (human)
|
|
IAGP
|
rs3130286
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,074,545...32,074,546
|
|
Q
|
GWAS1346270_H
|
Epstein-Barr virus seropositivity QTL GWAS1346270 (human)
|
|
IAGP
|
rs9276033
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,727,598...32,727,599
|
|
Q
|
GWAS1346271_H
|
Epstein-Barr virus seropositivity QTL GWAS1346271 (human)
|
|
IAGP
|
rs424232
| 8.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,240,547...32,240,548
|
|
Q
|
GWAS1346272_H
|
Epstein-Barr virus seropositivity QTL GWAS1346272 (human)
|
|
IAGP
|
rs28732242
| 1.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,476,301...32,476,302
|
|
Q
|
GWAS1346273_H
|
Epstein-Barr virus seropositivity QTL GWAS1346273 (human)
|
|
IAGP
|
rs2308818
| 7.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,581,579...32,581,580
|
|
Q
|
GWAS1346274_H
|
Epstein-Barr virus seropositivity QTL GWAS1346274 (human)
|
|
IAGP
|
rs647035
| 2.0E-16 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,608,849...32,608,850
|
|
Q
|
GWAS1346275_H
|
Epstein-Barr virus seropositivity QTL GWAS1346275 (human)
|
|
IAGP
|
rs9275599
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,714,652...32,714,653
|
|
Q
|
GWAS1346399_H
|
Epstein-Barr virus seropositivity QTL GWAS1346399 (human)
|
|
IAGP
|
rs9275563
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,135...32,710,136
|
|
Q
|
GWAS1346400_H
|
Epstein-Barr virus seropositivity QTL GWAS1346400 (human)
|
|
IAGP
|
rs9271644
| 5.0E-19 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,624,560...32,624,561
|
|
Q
|
GWAS1346401_H
|
Epstein-Barr virus seropositivity QTL GWAS1346401 (human)
|
|
IAGP
|
rs1048709
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,947,158...31,947,159
|
|
Q
|
GWAS1346402_H
|
Epstein-Barr virus seropositivity QTL GWAS1346402 (human)
|
|
IAGP
|
rs9267989
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,251,543...32,251,544
|
|
Q
|
GWAS1346403_H
|
Epstein-Barr virus seropositivity QTL GWAS1346403 (human)
|
|
IAGP
|
rs760293
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,644,000...31,644,001
|
|
Q
|
GWAS1346404_H
|
Epstein-Barr virus seropositivity QTL GWAS1346404 (human)
|
|
IAGP
|
rs3134943
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,179,984...32,179,985
|
|
Q
|
GWAS1346405_H
|
Epstein-Barr virus seropositivity QTL GWAS1346405 (human)
|
|
IAGP
|
rs2294878
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,400,018...32,400,019
|
|
Q
|
GWAS1346406_H
|
Epstein-Barr virus seropositivity QTL GWAS1346406 (human)
|
|
IAGP
|
rs3104415
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,614,800...32,614,801
|
|
Q
|
GWAS1347192_H
|
streptococcus seropositivity QTL GWAS1347192 (human)
|
|
IAGP
|
rs377763
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,231,367...32,231,368
|
|
Q
|
GWAS1347739_H
|
Epstein-Barr virus seropositivity QTL GWAS1347739 (human)
|
|
IAGP
|
rs45575033
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:30,987,836...30,987,837
|
|
Q
|
GWAS1347740_H
|
Epstein-Barr virus seropositivity QTL GWAS1347740 (human)
|
|
IAGP
|
rs4947344
| 3.0E-15 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,069...32,710,070
|
|
Q
|
GWAS1347741_H
|
Epstein-Barr virus seropositivity QTL GWAS1347741 (human)
|
|
IAGP
|
rs9271116
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,608,987...32,608,988
|
|
Q
|
GWAS1347742_H
|
Epstein-Barr virus seropositivity QTL GWAS1347742 (human)
|
|
IAGP
|
rs9268199
| 9.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,310,858...32,310,859
|
|
Q
|
GWAS1347906_H
|
Epstein-Barr virus seropositivity QTL GWAS1347906 (human)
|
|
IAGP
|
rs9269202
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,481,746...32,481,747
|
|
Q
|
GWAS1347907_H
|
Epstein-Barr virus seropositivity QTL GWAS1347907 (human)
|
|
IAGP
|
rs1049213
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,659,996...32,659,997
|
|
Q
|
GWAS1347908_H
|
Epstein-Barr virus seropositivity QTL GWAS1347908 (human)
|
|
IAGP
|
rs2760994
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,606,531...32,606,532
|
|
Q
|
GWAS1347909_H
|
Epstein-Barr virus seropositivity QTL GWAS1347909 (human)
|
|
IAGP
|
rs9270580
| 4.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,593,346...32,593,347
|
|
Q
|
GWAS1347910_H
|
Epstein-Barr virus seropositivity QTL GWAS1347910 (human)
|
|
IAGP
|
rs9275524
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,707,332...32,707,333
|
|
Q
|
GWAS1347911_H
|
Epstein-Barr virus seropositivity QTL GWAS1347911 (human)
|
|
IAGP
|
rs9275524
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,707,332...32,707,333
|
|
Q
|
GWAS1347912_H
|
Epstein-Barr virus seropositivity QTL GWAS1347912 (human)
|
|
IAGP
|
rs2041205
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 7:153,890,200...153,890,201
|
|
Q
|
GWAS1347913_H
|
Epstein-Barr virus seropositivity QTL GWAS1347913 (human)
|
|
IAGP
|
rs9275524
| 4.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,707,332...32,707,333
|
|
Q
|
GWAS1347914_H
|
Epstein-Barr virus seropositivity QTL GWAS1347914 (human)
|
|
IAGP
|
rs4947344
| 8.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,710,069...32,710,070
|
|
Q
|
GWAS1347915_H
|
Epstein-Barr virus seropositivity QTL GWAS1347915 (human)
|
|
IAGP
|
rs685810
| 7.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,617,175...32,617,176
|
|
Q
|
GWAS1347916_H
|
Epstein-Barr virus seropositivity QTL GWAS1347916 (human)
|
|
IAGP
|
rs112481371
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,599,774...32,599,775
|
|
Q
|
GWAS1347917_H
|
Epstein-Barr virus seropositivity QTL GWAS1347917 (human)
|
|
IAGP
|
rs9461776
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,607,958...32,607,959
|
|
Q
|
GWAS1347918_H
|
Epstein-Barr virus seropositivity QTL GWAS1347918 (human)
|
|
IAGP
|
rs9271406
| 4.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,619,811...32,619,812
|
|
Q
|
GWAS1348082_H
|
Epstein-Barr virus seropositivity QTL GWAS1348082 (human)
|
|
IAGP
|
rs6916742
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q
|
GWAS1348083_H
|
Epstein-Barr virus seropositivity QTL GWAS1348083 (human)
|
|
IAGP
|
rs3104415
| 6.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,614,800...32,614,801
|
|
Q
|
GWAS1348084_H
|
Epstein-Barr virus seropositivity QTL GWAS1348084 (human)
|
|
IAGP
|
rs28732242
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,476,301...32,476,302
|
|
Q
|
GWAS1348085_H
|
Epstein-Barr virus seropositivity QTL GWAS1348085 (human)
|
|
IAGP
|
rs6916742
| 3.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,485,414...32,485,415
|
|
Q
|
GWAS1348086_H
|
Epstein-Barr virus seropositivity QTL GWAS1348086 (human)
|
|
IAGP
|
rs9270578
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,593,316...32,593,317
|
|
Q
|
GWAS1348087_H
|
Epstein-Barr virus seropositivity QTL GWAS1348087 (human)
|
|
IAGP
|
rs9273529
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,660,921...32,660,922
|
|
Q
|
GWAS1348088_H
|
Epstein-Barr virus seropositivity QTL GWAS1348088 (human)
|
|
IAGP
|
rs9273529
| 6.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,660,921...32,660,922
|
|
Q
|
GWAS1351149_H
|
Epstein-Barr virus seropositivity QTL GWAS1351149 (human)
|
|
IAGP
|
rs3129898
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,454,348...32,454,349
|
|
Q
|
GWAS1546470_H
|
staphylococcus seropositivity QTL GWAS1546470 (human)
|
|
IAGP
|
rs410851
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,968,891...31,968,892
|
|
Q
|
GWAS1547144_H
|
Epstein-Barr virus seropositivity QTL GWAS1547144 (human)
|
|
IAGP
|
rs9268118
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,282,210...32,282,211
|
|
Q
|
GWAS1547145_H
|
Epstein-Barr virus seropositivity QTL GWAS1547145 (human)
|
|
IAGP
|
rs2857596
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,599,645...31,599,646
|
|
Q
|
GWAS1547146_H
|
Epstein-Barr virus seropositivity QTL GWAS1547146 (human)
|
|
IAGP
|
rs9266683
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,380,687...31,380,688
|
|
Q
|
GWAS1547147_H
|
Epstein-Barr virus seropositivity QTL GWAS1547147 (human)
|
|
IAGP
|
rs1153021
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr16:75,684,574...75,684,575
|
|
Q
|
GWAS1547148_H
|
Epstein-Barr virus seropositivity QTL GWAS1547148 (human)
|
|
IAGP
|
rs62404084
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,635,544...32,635,545
|
|
Q
|
GWAS1547149_H
|
Epstein-Barr virus seropositivity QTL GWAS1547149 (human)
|
|
IAGP
|
rs4705943
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 5:132,419,312...132,419,313
|
|
Q
|
GWAS1547457_H
|
Epstein-Barr virus seropositivity QTL GWAS1547457 (human)
|
|
IAGP
|
rs3129718
| 1.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,692,061...32,692,062
|
|
Q
|
GWAS1547458_H
|
Epstein-Barr virus seropositivity QTL GWAS1547458 (human)
|
|
IAGP
|
rs9267955
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,245,373...32,245,374
|
|
Q
|
GWAS1547459_H
|
Epstein-Barr virus seropositivity QTL GWAS1547459 (human)
|
|
IAGP
|
rs3117117
| 7.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,353,495...32,353,496
|
|
Q
|
GWAS1547460_H
|
Epstein-Barr virus seropositivity QTL GWAS1547460 (human)
|
|
IAGP
|
rs4959021
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,013,369...32,013,370
|
|
Q
|
GWAS1547461_H
|
Epstein-Barr virus seropositivity QTL GWAS1547461 (human)
|
|
IAGP
|
rs2857600
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,614,510...31,614,511
|
|
Q
|
GWAS1547462_H
|
Epstein-Barr virus seropositivity QTL GWAS1547462 (human)
|
|
IAGP
|
rs2596503
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,353,033...31,353,034
|
|
Q
|
GWAS1547463_H
|
Epstein-Barr virus seropositivity QTL GWAS1547463 (human)
|
|
IAGP
|
rs9271611
| 5.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,623,832...32,623,833
|
|
Q
|
GWAS1547464_H
|
Epstein-Barr virus seropositivity QTL GWAS1547464 (human)
|
|
IAGP
|
rs2596503
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,353,033...31,353,034
|
|
Q
|
GWAS1547465_H
|
Epstein-Barr virus seropositivity QTL GWAS1547465 (human)
|
|
IAGP
|
rs9275212
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,690,550...32,690,551
|
|
Q
|
GWAS1547466_H
|
Epstein-Barr virus seropositivity QTL GWAS1547466 (human)
|
|
IAGP
|
rs4947340
| 7.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,467,561...32,467,562
|
|
Q
|
GWAS1549080_H
|
Epstein-Barr virus seropositivity QTL GWAS1549080 (human)
|
|
IAGP
|
rs2050188
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q
|
GWAS1549081_H
|
Epstein-Barr virus seropositivity QTL GWAS1549081 (human)
|
|
IAGP
|
rs9268402
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,373,576...32,373,577
|
|
Q
|
GWAS1549088_H
|
Epstein-Barr virus seropositivity QTL GWAS1549088 (human)
|
|
IAGP
|
rs1437741
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 2:85,741,456...85,741,457
|
|
Q
|
GWAS1549089_H
|
Epstein-Barr virus seropositivity QTL GWAS1549089 (human)
|
|
IAGP
|
rs1437741
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 2:85,741,456...85,741,457
|
|
Q
|
GWAS1549090_H
|
Epstein-Barr virus seropositivity QTL GWAS1549090 (human)
|
|
IAGP
|
rs9272598
| 9.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,639,834...32,639,835
|
|
Q
|
GWAS1549091_H
|
Epstein-Barr virus seropositivity QTL GWAS1549091 (human)
|
|
IAGP
|
rs9268853
| 1.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,866...32,461,867
|
|
Q
|
GWAS1549092_H
|
Epstein-Barr virus seropositivity QTL GWAS1549092 (human)
|
|
IAGP
|
rs585305
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,604,271...32,604,272
|
|
Q
|
GWAS1549093_H
|
Epstein-Barr virus seropositivity QTL GWAS1549093 (human)
|
|
IAGP
|
rs9268849
| 2.0E-16 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,550...32,461,551
|
|
Q
|
GWAS1549094_H
|
Epstein-Barr virus seropositivity QTL GWAS1549094 (human)
|
|
IAGP
|
rs585305
| 2.0E-16 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,604,271...32,604,272
|
|
Q
|
GWAS1549095_H
|
Epstein-Barr virus seropositivity QTL GWAS1549095 (human)
|
|
IAGP
|
rs3129774
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,636,048...32,636,049
|
|
Q
|
GWAS1549096_H
|
Epstein-Barr virus seropositivity QTL GWAS1549096 (human)
|
|
IAGP
|
rs9268849
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,550...32,461,551
|
|
Q
|
GWAS1549097_H
|
Epstein-Barr virus seropositivity QTL GWAS1549097 (human)
|
|
IAGP
|
rs9268853
| 3.0E-19 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,461,866...32,461,867
|
|
Q
|
GWAS1549098_H
|
Epstein-Barr virus seropositivity QTL GWAS1549098 (human)
|
|
IAGP
|
rs9272598
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,639,834...32,639,835
|
|
Q
|
GWAS1549099_H
|
Epstein-Barr virus seropositivity QTL GWAS1549099 (human)
|
|
IAGP
|
rs9268833
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,460,285...32,460,286
|
|
Q
|
GWAS1549100_H
|
Epstein-Barr virus seropositivity QTL GWAS1549100 (human)
|
|
IAGP
|
rs2050188
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q
|
GWAS1549101_H
|
Epstein-Barr virus seropositivity QTL GWAS1549101 (human)
|
|
IAGP
|
rs3132557
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,138,632...31,138,633
|
|
Q
|
GWAS1549412_H
|
Epstein-Barr virus seropositivity QTL GWAS1549412 (human)
|
|
IAGP
|
rs34452456
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,482,901...32,482,902
|
|
Q
|
GWAS1549413_H
|
Epstein-Barr virus seropositivity QTL GWAS1549413 (human)
|
|
IAGP
|
rs2050188
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q
|
GWAS1549414_H
|
Epstein-Barr virus seropositivity QTL GWAS1549414 (human)
|
|
IAGP
|
rs6457715
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:33,115,411...33,115,412
|
|
Q
|
GWAS1549415_H
|
Epstein-Barr virus seropositivity QTL GWAS1549415 (human)
|
|
IAGP
|
rs28496707
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:33,000,710...33,000,711
|
|
Q
|
GWAS1549416_H
|
Epstein-Barr virus seropositivity QTL GWAS1549416 (human)
|
|
IAGP
|
rs9268435
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,378,714...32,378,715
|
|
Q
|
GWAS1549417_H
|
Epstein-Barr virus seropositivity QTL GWAS1549417 (human)
|
|
IAGP
|
rs11582858
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 1:9,454,514...9,454,515
|
|
Q
|
GWAS1549418_H
|
Epstein-Barr virus seropositivity QTL GWAS1549418 (human)
|
|
IAGP
|
rs9268402
| 9.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,373,576...32,373,577
|
|
Q
|
GWAS1549419_H
|
Epstein-Barr virus seropositivity QTL GWAS1549419 (human)
|
|
IAGP
|
rs2050188
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,372,120...32,372,121
|
|
Q
|
GWAS1549420_H
|
Epstein-Barr virus seropositivity QTL GWAS1549420 (human)
|
|
IAGP
|
rs6927022
| 3.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,644,620...32,644,621
|
|
Q
|
GWAS1549421_H
|
Epstein-Barr virus seropositivity QTL GWAS1549421 (human)
|
|
IAGP
|
rs3132557
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,138,632...31,138,633
|
|
Q
|
GWAS1549422_H
|
Epstein-Barr virus seropositivity QTL GWAS1549422 (human)
|
|
IAGP
|
rs596701
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr18:2,828,701...2,828,702
|
|
Q
|
GWAS1549423_H
|
Epstein-Barr virus seropositivity QTL GWAS1549423 (human)
|
|
IAGP
|
rs176095
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,190,542...32,190,543
|
|
Q
|
GWAS1549424_H
|
Epstein-Barr virus seropositivity QTL GWAS1549424 (human)
|
|
IAGP
|
rs35242582
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,632,280...32,632,281
|
|
Q
|
GWAS1549425_H
|
Epstein-Barr virus seropositivity QTL GWAS1549425 (human)
|
|
IAGP
|
rs7452864
| 6.0E-14 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,471,300...32,471,301
|
|
Q
|
GWAS1549426_H
|
Epstein-Barr virus seropositivity QTL GWAS1549426 (human)
|
|
IAGP
|
rs3135461
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,712,345...32,712,346
|
|
Q
|
GWAS1549427_H
|
Epstein-Barr virus seropositivity QTL GWAS1549427 (human)
|
|
IAGP
|
rs7773105
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:31,361,595...31,361,596
|
|
Q
|
GWAS1549428_H
|
Epstein-Barr virus seropositivity QTL GWAS1549428 (human)
|
|
IAGP
|
rs35880697
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,465,982...32,465,983
|
|
Q
|
GWAS1549429_H
|
Epstein-Barr virus seropositivity QTL GWAS1549429 (human)
|
|
IAGP
|
rs35880697
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,465,982...32,465,983
|
|
Q
|
GWAS1549430_H
|
Epstein-Barr virus seropositivity QTL GWAS1549430 (human)
|
|
IAGP
|
rs41291798
| 8.0E-10 |
|
|
GWAS_CATALOG |
PMID:37164013 |
|
NCBI chr 6:32,463,781...32,463,782
|
|
|
Q
|
GWAS1116951_H
|
rheumatoid factor seropositivity measurement, rheumatoid factor measurement QTL GWAS1116951 (human)
|
|
IAGP
|
rs1502644
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:26815016 |
|
NCBI chr 5:3,670,892...3,670,893
|
|
Q
|
GWAS1669978_H
|
rheumatoid factor measurement QTL GWAS1669978 (human)
|
|
IAGP
|
rs34434863
| 5.0E-13 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 6:32,591,896...32,591,897
|
|
Q
|
GWAS1669979_H
|
rheumatoid factor measurement QTL GWAS1669979 (human)
|
|
IAGP
|
rs34434863
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 6:32,591,896...32,591,897
|
|
Q
|
GWAS1670491_H
|
rheumatoid factor measurement QTL GWAS1670491 (human)
|
|
IAGP
|
rs34434863
| 6.0E-13 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 6:32,591,896...32,591,897
|
|